merck & co. news - Search News

Modifi, Merck and yale university

Connecticut, USA-based Modifi Biosciences today announced that the company has been acquired by pharma giant Merck & Co (NYSE: MRK). Modifi Biosciences was formed in 2021 based on technology spun out of Yale University.

Hartford Business · 5h

Merck acquires Yale-spinout Modifi Bio in $1.3B deal

Modifi Biosciences, a New Haven startup biotech that focuses on developing cancer therapies, has been acquired by biopharmaceutical giant Merck & Co. Inc. in a $1.3 billion deal, the companies announced Wednesday.

MarketWatch · 7h

Merck Buys Yale Cancer-Therapy Spinout Modifi Biosciences

Merck & Co. has acquired Modifi Biosciences, a developer of cancer therapies that was spun out of Yale University, in a deal potentially worth more than $1 billion.

Reuters on MSN · 8h

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of the deal, the U.S.

TMCnet · 10h

Modifi Biosciences Acquired by Merck

In founding Modifi Biosciences, we sought to radically change the oncology treatment paradigm for cancer patients with glioblastoma and other tumors,” said Ranjit S. Bindra, MD, PhD, Modifi Biosciences Co-founder,

1hon MSN

CDC Panel Favors Wider Use of Pfizer, Merck Pneumococcal Shots

A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and ...

7hon MSN

Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?

We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are ...

BioPharma Dive5h

Merck acquires cancer drug startup; Elevidys ex-US sales rise

Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...

FierceBiotech10h

Merck sets sights on brain cancer with $30M Modifi acquisition

Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset ...

The Journal21h

Merck Animal Health introduces SENSEHUB Dairy Youngstock

Merck Animal Health, a division of Merck & Co., Inc., Rahway, New Jersey, has introduced SENSEHUB Dairy Youngstock, the ...

Merck & Company (MRK) Receives a Buy from Jefferies

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...

Zacks Research Predicts Lower Earnings for Merck & Co., Inc.

Zacks Research lowered their Q3 2024 earnings estimates for Merck & Co., Inc. in a report issued on Monday, October 21st.

FierceBiotech2d

Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks, setting stage for pivotal program

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...

Yahoo Finance1d

Merck & Co., Inc. (MRK)

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical study evaluating the investigational combination of islatravir and ...

Barchart on MSN6d

Here's What to Expect From Merck & Co.'s Next Earnings Report

Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results